Mic1-3基因敲除弓形虫活疫苗株在猫宿主中的免疫原性与保护效果评价
本研究在猫宿主中测试了缺失Mic1和Mic3基因的弓形虫减毒活疫苗株(Mic1-3KO),该株此前在小鼠和羊模型中显示为有效疫苗候选。皮下或口服接种均诱导猫血清产生高滴度特异性抗体,表明该株对猫具有免疫原性。然而,无论接种途径如何,高抗体滴度均未能阻止猫在口服攻击后排出野生型弓形虫卵囊。
要点
- Mic1-3KO减毒活疫苗株在猫中具有免疫原性,皮下或口服接种均诱导高滴度特异性抗体。
- 高抗体滴度未能阻止接种猫在口服野生型弓形虫攻击后排出卵囊。
- 该疫苗候选株在猫宿主中耐受良好且安全,但不提供对抗卵囊排出的保护。
核心结论
- Mic1-3KO疫苗候选株在猫宿主中具有免疫原性、耐受良好且安全,但不能提供对抗野生型弓形虫感染后卵囊排出的保护。
研究设计与样本
- 在猫中测试缺失Mic1和Mic3基因的弓形虫减毒活疫苗株(Mic1-3KO),采用皮下或口服接种途径,并以口服野生型弓形虫攻击后随访卵囊排出。
主要发现
- 皮下或口服接种均诱导猫血清产生高滴度特异性抗体,表明Mic1-3KO株对猫具有免疫原性。
- 无论接种途径如何,高抗体滴度均未能阻止猫在口服野生型弓形虫攻击后排出卵囊。
局限性
- 作者指出该结果突显了弓形虫与其唯一终末宿主之间的特殊关系,表明需要进一步研究以改进疫苗策略以限制环境和牲畜污染。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Toxoplasmosis is a zoonotic disease caused by the parasite Toxoplasma gondii. Up to a third of the global human population is estimated to carry a T. gondii infection, which can result in severe complications in immunocompromised individuals and pregnant women. Humans and animals can become infected by ingesting either tissue cysts containing T. gondii bradyzoites, from raw or undercooked meat, or sporulated oocysts from environmental sources. T. gondii oocysts are released in the faeces of cats and other felids, which are the parasite's definitive hosts, leading to environmental contamination. Therefore, vaccination of the feline host against T. gondii is an interesting strategy to interrupt the parasitic life cycle and subsequently limit contamination of intermediate hosts. With this goal in mind, we tested in cats, an attenuated live strain of T. gondii deleted for the Mic1 and Mic3 genes (Mic1-3KO) that was previously shown to be an efficient vaccine candidate in mouse and sheep models. Subcutaneous or oral vaccination routes induced a high specific antibody titer in the cat sera, indicating that the Mic1-3KO strain is immunogenic for cats. To assess protection induced by the vaccine candidate strain, we followed oocysts shedding by vaccinated cats, after oral challenge with a T. gondii wild-type strain. Surprisingly, a high antibody titer did not prevent cats from shedding oocysts from the challenge strain, regardless of the vaccination route. Our results show that the Mic1-3KO vaccine candidate is immunogenic in the feline host, is well tolerated and safe, but does not confer protection against oocysts shedding after natural infection with wild type T. gondii. This result highlights the particular relationship between T. gondii and its unique definitive host, which indicates the need for further investigations to improve vaccination strategies to limit environmental and livestock contaminations.
引用
- Le Roux D, Djokic V, Morisse S, et al. Evaluation of immunogenicity and protection of the Mic1-3 knockout Toxoplasma gondii live attenuated strain in the feline host. Vaccine. 2019. PMID: 31864855. doi:10.1016/j.vaccine.2019.11.076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。